companyprofile

Actions

Dallah Healthcare Co.

4004
DALLAH HEALTH
Add To Watchlist
In your Watchlist
Add To Watchlist
  • Main Market
  • Health Care Equipment & Svc

Stats Overview

  • Prev. Close 167.60
  • Open 169.00
  • High 169.00
  • Low 164.00
  • No. of Trades 830
  • Avg. Trade size* 155
  • Volume Traded 128,869
  • Value Traded (SAR) 21,232,612.60

Performance

DALLAH HEALTH
-3.40 ( -2.03% )
Compare
Name Price Change %
Dallah Healthcare Co. 169.00 -2.03%
Note: Prices are delayed minimum 5 minutes
  • *Average Trade Size = Cumulative / # of Trades
  • **52 Week Price Change =   (Current Price - Price year ago) / Price year ago x 100
  • Historical prices & volume traded data are adjusted to account for all corporate actions.
  • MO: Market Order

Trade Updates

Last Trade

Price
164.20
% Change
-2.03
Volume Traded
3

Best Bid

Price 164.00
Volume 835

Best Offer

Price 164.20
Volume 528

52 WEEK

High
194.00
2024/02/26
Low
131.40
2023/09/19
Change**
-2.26

PERFORMANCE

Start of Year
170.4
Year ago
168
3 Years ago
78

Compare Selected

Select a Maximum of 5 Companies

Compare Selected

LoginPortletPopupv2

Actions

AddtoWatchlistv2

Actions

Add to watchlist

AnnouncmentandCorporateAction

Actions
Jump To :
  • Announcements & Corporate Actions
  • Dividends
  • Financials
  • Shareholding
  • Peer Comparison
  • Company Profile

Announcements

  • Correction announcement from Dallah Healthcare Co. regarding the Board's invitation to its shareholders to attend the Ordinary General Assembly Meeting (First Meeting).

    4004
    DALLAH HEALTH -2.03 %
    1445/12/07     13/06/2024 08:01:40
  • Dallah Healthcare Co. announces the board of director’s recommendation to distribute cash dividends for the first quarter of the fiscal year 2024

    4004
    DALLAH HEALTH -2.03 %
    1445/12/06     12/06/2024 09:03:27
  • Dallah Healthcare Co. Board invites its shareholders to attend the Ordinary General Assembly Meeting the ( First Meeting )

    4004
    DALLAH HEALTH -2.03 %
    1445/11/15     23/05/2024 15:40:32
  • Dallah Healthcare Co. announces its Interim Financial results for the Period Ending on 2024-03-31 ( Three Months )

    4004
    DALLAH HEALTH -2.03 %
    1445/11/05     13/05/2024 09:08:26
  • Dallah Healthcare Co. announces its Annual Financial results for the period ending on 2023-12-31

    4004
    DALLAH HEALTH -2.03 %
    1445/09/04     14/03/2024 08:32:31
View All

Corporate Actions

Upcoming Events

    Past Events

      Jump To :
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Dividends

      Announced Date Eligibility Date Distribution Date Distribution Way Dividend Amount
      12/06/2024 N/A N/A Account Transfer 0.50
      26/12/2023 16/01/2024 30/01/2024 Account Transfer 0.50
      06/11/2023 12/11/2023 26/11/2023 Account Transfer 0.50
      08/08/2023 24/08/2023 07/09/2023 Account Transfer 0.50
      20/06/2023 06/07/2023 20/07/2023 Account Transfer 0.50

      CompanyProfilev2Financials

      Actions
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Financials

      • FINANCIAL INFORMATION
      • FINANCIAL STATEMENTS AND REPORTS
      • Annually
      • Quarterly
      Balance Sheet 2023-12-31
      Total Assets
      6,242,854.7
      - - -
      Total Liabilities
      2,770,202.7
      - - -
      Total Shareholders Equity (After Deducting the Minority Equity)
      3,203,392.97
      - - -
      Total Liabilities and Shareholders Equity
      5,973,595.67
      - - -
      Statement of Income 2023-12-31
      Total Revenue (Sales/Operating)
      2,942,897.7
      - - -
      Net Profit (Loss) before Zakat and Tax
      400,315.32
      - - -
      Zakat and Income Tax
      -14,890.48
      - - -
      Net Profit (Loss) after Zakat and Tax
      385,424.84
      - - -
      Total Comprehensive Income
      392,826.36
      - - -
      Profit (Loss) per Share
      3.7
      - - -
      Cash Flow 2023-12-31
      Net Cash From Operating Activities
      625,783.84
      - - -
      Net Cash From Investing Activities
      -293,684.95
      - - -
      Net Cash From Financing Activities
      -334,736.08
      - - -
      Cash and Cash Equivalents, Beginning of the Period
      237,944.91
      - - -
      Cash and Cash Equivalents, End of the Period
      235,307.72
      - - -
      All Figures in Thousands
      All Currency In SAR
      Last Update Date 2024-05-12

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.

      Balance Sheet 2023-09-30
      Total Assets
      6,103,341.13
      Total Liabilities
      2,650,476.55
      Total Shareholders Equity (After Deducting the Minority Equity)
      3,188,198.8
      Total Liabilities and Shareholders Equity
      5,838,675.36
      Statement of Income 2023-09-30
      Total Revenue (Sales/Operating)
      749,827.77
      Net Profit (Loss) before Zakat and Tax
      111,322.55
      Zakat and Income Tax
      -4,989.96
      Net Profit (Loss) after Zakat and Tax
      106,332.59
      Total Comprehensive Income
      111,587.95
      Profit (Loss) per Share
      1.01
      Cash Flow 2023-09-30
      Net Cash From Operating Activities
      355,889.25
      Net Cash From Investing Activities
      -158,252.03
      Net Cash From Financing Activities
      -292,358.52
      Cash and Cash Equivalents, Beginning of the Period
      237,944.91
      Cash and Cash Equivalents, End of the Period
      143,223.61
      All Figures in Thousands
      All Currency In SAR
      Last Update Date 2024-01-10

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.

      Display Previous Periods
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Shareholding Information

      • Board Of Directors
      • Foreign Ownership
      • Substantial Shareholders
      Time Period
      -
      Search
      Trading Date Shareholders Designation Shares Held Trading Day Shares Held Prev Trading Day Change
      2024-06-13 طارق عثمان عبدالله القصبي Chairman 4.5151836% 4.5151836% 0
      2024-06-13 محمد راشد محمد الفقيه Board of Directors 4.8332613% 4.8332613% 0
      2024-06-13 احمد صالح محمد بابعير Senior Executives 0.0019502% 0.0019502% 0
      2024-06-13 فهد عبدالله عبدالعزيز القاسم Board of Directors 0.0019502% 0.0019502% 0
      2024-06-13 محي الدين صالح عبدالله كامل Board of Directors 0.0015612% 0.0015612% 0
      • The listed company (Publisher) shall be responsible for the accuracy of the published information pertaining to the ownership of the Board of Directors, Chief Executive Officer or highest executive position, and the Chief Financial Officer. The listed company shall also be responsible for updating these information thereof. Therefore, the Saudi Stock Exchange (Tadawul) shall not be liable for the information contained therein, nor for any consequences that may result from the said information.
      for
      subs
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Peer Comparison

      • Table
      • Graphical
      Add Company

      Compare Selected

      Select a Maximum of 5 Companies

      Company Apply
      Dallah Healthcare Co.
      Price 164.20
      Market Cap (SAR MN) 16,371
      P/E Ratio 42.54
      Index Name Index Level 1D Return
      Dallah Healthcare Co. %
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Company Profile

      Company overview

      The main core business for Dallah Health is hospitals. The company runs its two hospitals. The Hospital provides medical services for its outpatient, inpatients, specialized clinics, and hypnosis departments. Besides hospitals, Dallah health has other business activities: Dallah pharma trade manufactures and distributes the medicines. Dallah health manages and operates other hospitals and provides support services in maintenance for hospitals and medical centers. We also have investments and shares in other companies in the healthcare industry in MENA, in which Dallah health invests heavily in other companies in the health care industry.

      Company History

      Dallah Health is a joint stock company listed in the Saudi TADAWL since November 2012 under commercial registration: 1010128530 dated September 19 1994 under code number (4004) in the health care Sector''s main market. The company''s capital consists of ninety-seven million, six hundred eighty-one thousand and one hundred sixty-six (97,681,166) ordinary shares. With a nominal value of 10 riyals paid in full and a total value of nine hundred seventy-six million eight hundred eleven thousand six hundred sixty (976,811,660) Saudi Riyals

      Company Bylaws

      Click here

      Equity Profile

      • Authorized Capital (SAR) 976,811,660
      • Issued Shares 97,681,166
      • Paid Capital (SAR) 976,811,660
      • Par Value/Share 10
      • Paid Up Value/Share 10

      Last Update :2023-01-16

      Investment limits

      There are no investment limits on the company shares as per the amended Rules for Qualified Foreign Financial Institutions Investment in Listed Securities and Instructions for the Foreign Strategic Investors Ownership in Listed Companies based on company bylaw and the issued instructions by the related regulators and supervisory authorities

       

      • Company Details
      • BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
      • Date Established

        1994/09/19

      • Financial Year End

        31/12

      • Listing Date

        2012/11/17

      • External Auditors

        [KPMG]

      • ISIN CODE

        SA135G51UI10

      • Number of Employees

        -

      • Chairman

        Eng. Tarek Othman Alkasabi
        Non - Executive

        Eng. Tarek Othman Alkasabi
        • BD Session Start
          2022-10-21
          Designation
          Chairman
        • BD Session End
          2025-10-20
          Classification
          Non - Executive
      • Board of Directors

        Eng. Talal Ibrahim Al-Maiman Independent

        Eng. Talal Ibrahim Al-Maiman
        • BD Session Start
          2022-10-21
          Designation
          Board of Directors
        • BD Session End
          2025-10-20
          Classification
          Independent

        Mr. Abdullah Turki Al-Sudairy Independent

        Mr. Abdullah Turki Al-Sudairy
        • BD Session Start
          2022-10-21
          Designation
          Board of Directors
        • BD Session End
          2025-10-20
          Classification
          Independent

        Mr. Fahad Abdullah Al kassim Non - Executive

        Mr. Fahad Abdullah Al kassim
        • BD Session Start
          2022-10-21
          Designation
          Board of Directors
        • BD Session End
          2025-10-20
          Classification
          Non - Executive

        Dr. Mohammed Rashid Al-Fagih Non - Executive

        Dr. Mohammed Rashid Al-Fagih
        • BD Session Start
          2022-10-21
          Designation
          Board of Directors
        • BD Session End
          2025-10-20
          Classification
          Non - Executive

        Mr. Muhei Addein Saleh Kamel Deputy Chairman - Non Executive

        Mr. Muhei Addein Saleh Kamel
        • BD Session Start
          2022-10-21
          Designation
          Board of Directors
        • BD Session End
          2025-10-20
          Classification
          Deputy Chairman - Non Executive

        Mr. Amr Mohammed Kamel Non - Executive

        Mr. Amr Mohammed Kamel
        • BD Session Start
          2022-10-21
          Designation
          Board of Directors
        • BD Session End
          2025-10-20
          Classification
          Non - Executive

        Eng. Mohamed Nabil Hefni Non - Executive

        Eng. Mohamed Nabil Hefni
        • BD Session Start
          2022-10-21
          Designation
          Board of Directors
        • BD Session End
          2025-10-20
          Classification
          Non - Executive

        Mr. Khalid Mohammed AlSolai Independent

        Mr. Khalid Mohammed AlSolai
        • BD Session Start
          2023-03-06
          Designation
          Board of Directors
        • BD Session End
          2025-10-20
          Classification
          Independent
      • Senior Executives

        Dr. Ahmad Saleh Babaeer CEO

        Dr. Ahmad Saleh Babaeer
        • BD Session Start
          2008-03-29
          Designation
          Senior Executives
        • BD Session End
          -
          Classification
          CEO

        Mr.Amine bin Abderraouf Hariz CFO

      Mr.Amine bin Abderraouf Hariz
      • BD Session Start
        2024-05-26
        Designation
        Senior Executives
      • BD Session End
        -
        Classification
        CFO

      Investor Relations

      Contact Name:

      Investor Relations

      Company Address:

      Nakheel building, 1157 King Fahad Road, 2nd fl., Nakheel District, Riyadh, KSA

      Contact Details:

      Telephone: 0112255065-5001
      Fax : 0114550803
      Email : IR@dallahhealth.com

      Company Website:

      www.dallahhealth.com


      Add To Watchlist
      In your Watchlist
      Add To Watchlist

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.